Differential humoral response against α- and β-linked mannose residues associated with tissue invasion by Candida albicans

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 3, 1997, Pages 328-333

  Jouault, Thierry ^a   Delaunoy, Christian ^a   Sendid, Boualem ^b   Ajana, Faiza ^c   Poulain, Daniel ^a,b  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Hopital Dron   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FUNGUS ANTIGEN; IMMUNOGLOBULIN G; MANNAN; MANNOSE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0031011643     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.3.328-333.1997     Document Type: Article

References (51)

1. Beck-Sagué, C., and W. Jarvis. 1993. Nosocomial infection surveillance system. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
2. Bodey, G., E. Anaissie, L. Elting, E. Estey, S. O'Brien, and H. Kantarjian. 1994. Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B. Cancer 73:2099-2106.
3. Bougnoux, M., C. Hill, D. Moissenet, M. Feuilhade de Chauvin, M. Bonnay, I. Vincens-Sprauel, F. Pietri, M. McNell, L. Kaufman, J. Dupouy-Camet, C. Bohuon, and A. Andremont. 1990. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated candidiasis. J. Clin. Microbiol. 28:905-909.
4. Cantelli, C., P. Trinel, A. Bernigaud, T. Jouault, L. Polonelli, and D. Poulain. 1995. Mapping of β-1,2 linked oligomannosidic epitopes among glycoconjugates of Candida species. Microbiology 141:2693-2697.
5. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:4211-4218.
6. Case, C., A. Macgowan, N. Brown, D. Reeves, P. Witehead, and D. Femingham. 1991. Prophylactic oral fluconazole and Candida fungemia. Lancet 339:790.
7. Cassone, A., M. Boccanera, D. Adriani, G. Santoni, and F. De Bernardis. 1995. Rats cleaning a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun. 63:2619-2624.
8. Castro, M., N. V. C. Ralston, T. I. Morgenthaler, M. S. Rohrbach, and A. H. Limper. 1994. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect. Immun. 62:3138-3145.
9. Chew, W., and T. Theus. 1967. Candida precipitins. J. Immunol. 98:220-224.
10. Crampin, A., and R. Matthews. 1993. Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an hsp 90 gene fragment. J. Med. Microbiol. 39:233-238.
11. Domer, J. 1989. Candida cell wall mannan: a polysaccharide with diverse immunological properties. Crit. Rev. Microbiol. 17:33-51.
12. Dupont, B., J. Graybill, D. Armstrong, R. Laroche, J. Touze, and L. Wheat. 1992. Fungal infections in AIDS patients. J. Med. Vet. Mycol. 30:19-28.
13. Edwards, J. 1991. Invasive Candida infections. Evolution of a fungal pathogen. N. Engl. J. Med. 324:1060-1062.
14. Faille, C., J. C. Michalski, G. Strecker, D. W. R. Mackenzie, D. Camus, and D. Poulain. 1990. Immunoreactivity of neoglycolipids constructed from oligomannosidic residues of the Candida albicans cell wall. Infect. Immun. 58:3537-3544.
15. Faille, C., J. Wieruszeski, G. Lepage, J. Michalski, D. Poulain, and G. Strecker. 1991. 1H-NMR spectroscopy of manno-oligosaccharides of the β-1,2-linked series released from the phosphopeptidomannan of Candida albicans VW32 (serotype A). Biochem. Biophys. Res. Commun. 181:1251-1258.
16. Fukazawa, Y. 1989. Antigenic structure of Candida albicans: immunochemical basis of the serologic specificity of the mannans in yeasts, p. 37-62. In E. Kurstak (ed.), Immunology of fungal diseases. Marcel Dekker Inc., New York, N.Y.
17. Garner, R. E., K. Rubanowice, R. T. Sawyer, and J. A. Hudson. 1994. Secretion of TNF-α by alveolar macrophages in response to Candida albicans mannan. J. Leukocyte Biol. 55:161-168.
18. Guiot, H., W. Fibbe, and J. Van't Wout. 1994. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin. Infect. Dis. 18:525-532.
19. Han, Y., and J. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
20. Hernando, F., J. Cailliez, P. Trinel, C. Faille, D. Mackenzie, and D. Poulain. 1993. Qualitative and quantitative differences in recognition patterns of Candida albicans protein and polysaccharide antigens by human sera. J. Med. Vet. Mycol. 31:219-226.
21. Hopwood, V., and E. Evans. 1991. Serological tests in the diagnosis and prognosis of fungal infections in the compromised patient, p. 311-353. In W. Warnock and M. Richardson (ed.), Fungal infection in the compromised patient. John Wiley, New York, N.Y.
22. Iwama, A., M. Yoshida, A. Miwa, T. Obayashi, S. Sakamoto, and Y. Miura. 1993. Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur. J. Haematol. 51:156-160.
23. Jouault, T., A. Bernigaud, G. Lepage, P. Trinel, and D. Poulain. 1994. The Candida albicans phospholipomannan induces in vitro production of TNF-α production from human and murine macrophages. Immunology 83:268-273.
24. Jouault, T., G. Lepage, A. Bernigaud, P.-A. Trinel, C. Fradin, J.-M. Wieruszeski, G. Strecker, and D. Poulain. 1995. β-1,2-Oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect. Immun. 63:2378-2381.
25. Li, R., and J. Cutler. 1993. Chemical definition of an epitope/adhesin molecule on Candida albicans. J. Biol. Chem. 268:18293-18299.
26. Matthews, R., and J. Burnie. 1988. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen. J. Clin. Microbiol. 26:459-163.
27. Matthews, R., J. Burnie, and W. Lee. 1991. The application of epitope mapping in the development of a new serological test for systemic candidiosis. J. Immunol. Methods 143:73-79.
28. Matthews, R., J. Burnie, and S. Tabaqchali. 1984. Immunoblot analysis of the serological response in systemic candidosis. Lancet ii:1415-1418.
29. Menichetti, F., A. Del Favero, P. Martino, G. Bucaneve, A. Micozzi, D. D'Antonio, P. Ricci, M. Carotenaou, V. Liso, and A. Nosari. 1994. Preventing fungal infection in neurotropic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann. Intern. Med. 120:913-918.
30. Mitsutake, K., S. Kohno, T. Miyazaki, H. Miyazaki, S. Maesaki, and H. Koga. 1994. Detection of Candida enolase antibody in patients with candidiasis. J. Clin. Lab. Anal. 8:207-210.
31. Miyakawa, Y., K. Kagaya, Y. Fukazawa, and G. Soe. 1986. Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans. J. Clin. Microbiol. 23:881-886.
32. Nakamura, A., N. Ishikawa, and H. Suzuki. 1991. Diagnosis of invasive candidiasis by detection of mannan antigen by using avidin-biotin enzyme immunoassay. J. Clin. Microbiol. 29:2363-2367.
33. Nelson, R. D., N. Shibata, R. P. Podzorski, and M. J. Herron. 1991. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanism of action. Clin. Microbiol. Rev. 4:1-19.
34. Obayashi, T., M. Yoshida, T. Mori, H. Goto, A. Yasuoka, H. Iwasaki, H. Teshima, S. Kohno, A. Horiuchi, A. Ito, H. Yamaguchi, K. Shimada, and T. Kawal. 1995. Plasma (1->3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 7:17-20.
35. Odds, F., and E. Evans. 1980. Distribution of pathogenic yeasts and humoral antibodies to Candida among hospital patients. J. Clin. Pathol. 33:750-756.
36. Poulain, D., C. Faille, C. Delaunoy, P. M. Jacquinot, P. A. Trinel, and D. Camus. 1993. Probable presence of β(1-2)-linked oligomannosides that act as human immunoglobulin G3 epitopes and are distributed over a Candida albicans 14- to 18-kilodalton antigen. Infect. Immun. 61:1164-1166.
37. Poulain, D., R. Robert, and A. Cassone. Unpublished data.
38. Reiss, E., and C. Morrison. 1993. Nonculture methods for diagnosis of disseminated candidiasis. Clin. Microbiol. Rev. 6:311-323.
39. San Bias, G., S. Suzuki, V. Hearn, C. Pinel, H. Kobayashi, C. Mendez, G. Nino, A. Nishikawa, F. San Bias, N. Shibata, T. Shinoda, F. Sorais, and H. Yamaguchi. 1994. Fungal polysaccharides. J. Med. Vet. Mycol. 32(Suppl. 1):312-328.
40. Shibata, N., M. Arai, E. Haga, T. Kikuchi, M. Najima, T. Satoh, H. Kobayashi, and S. Suzuki. 1992. Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as β-1,2-linked oligomannosyl residues. Infect. Immun. 60:4100-4110.
41. Shibata, N., K. Hisamichi, H. Kobayashi, and S. Suzuki. 1993. Complete assignment of 1H and 13C nuclear magnetic resonance chemical shifts of β-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Arch. Biochem. Biophys. 302:113-117.
42. Sternberg, S. 1994. The emerging fungal threat. Science 266:1632-1634.
43. Suzuki, S., N. Shibata, and H. Kobayashi. 1991. Immunochemistry of Candida mannans, p. 111-121. In J. P. Latgé and D. Boucias (ed.), Fungal cell wall and immune response. Springer-Verlag, Berlin, Germany.
44. Switchenko, A., C. Miyada, T. Goodman, T. Walsh, B. Wong, M. Becker, and E. Ullman. 1994. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J. Clin. Microbiol. 32:92-97.
45. Tojo, M., N. Shibata, M. Kobayashi, T. Mikami, M. Suzuki, and S. Suzuki. 1988. Preparation of monoclonal antibodies reactive with β-1,2-linked oligomannosyl residues in the phosphomannan-protein complex of Candida albicans NIH B-792 strain. Clin. Chem. 34:539-543.
46. Trinel, P.-A., M. Borg-von-Zepelin, G. Lepage, T. Jouault, D. Mackenzie, and D. Poulain. 1993. Isolation and preliminary characterization of the 14-to 18-kilodalton Candida albicans antigen as a phospholipomannan containing β-1,2-linked oligomannosides. Infect. Immun. 61:4398-4405.
47. Trinel, P., C. Faille, P. Jacquinot, J. Cailliez, and D. Poulain. 1992. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies. Infect. Immun. 60:3845-3851.
48. Trinel, P., T. Jouault, and D. Poulain. 1996. The Candida phospholipomannan, a molecule sharing structural and functional identity with microbial pathogenicity determinants, p. 4398-4405. In Topics in mycology. The National Foundation for Infectious Diseases, Bethesda, Md.
49. Van Devanter, A., H. Van Vliet, W. Hop, and W. Goessens. 1994. Diagnostic value of anti-Candida enolase antibodies. J. Clin. Microbiol. 32:17-23.
50. Walsh, T., W. Hathom, J. Sobel, W. Herz, V. Sanchez, M. Maret, H. Buckley, H. Pfaller, R. Schausele, C. Silva, E. Navaro, J. Lecciones, P. Chandrasekar, J. Lee, and P. Pizzo. 1991. Detection of circulating Candida enolase by immunoassay in cancer patients with invasive candidiasis. N. Engl. J. Med. 15:1026-1031.
51. Wey, S., M. Mori, M. Pfaller, R. Woolson, and R. Wenzel. 1989. Risk factors for hospital acquired candidemia, a matched case-control study. Arch. Intern. Med. 149:2349-2353.